Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA approves Amgen drug for secondary hyperparathyroidism
FDA approves Amgen drug for secondary hyperparathyroidism
FDA approves Amgen drug for secondary hyperparathyroidism
Submitted by
admin
on February 8, 2017 - 9:18am
Source:
Yahoo/Reuters
News Tags:
FDA
Amgen
secondary hyperparathyroidism
kidney disease
etelcalcetide
Headline:
FDA approves Amgen drug for secondary hyperparathyroidism
Do Not Allow Advertisers to Use My Personal information
